Ocean Bio-Chem Inc
OBCI
OBCI was delisted on the 8th of August, 2022.
0 hedge funds and large institutions have $0 invested in Ocean Bio-Chem Inc in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 17 closing their positions.
100% less funds holding
Funds holding: 17 → 0 (-17)
100% less capital invested
Capital invested by funds: $10.5M → $0 (-$10.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 17
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$3.03M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2M |
| 3 |
AC
AltraVue Capital
Bellevue,
Washington
|
-$1.54M |
| 4 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
-$1.11M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.06M |
OBCI Hedge Fund Activity: Q3 2022 in Review
0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Ocean Bio-Chem Inc (OBCI) for Q3 2022, worth a combined $0 — down 100% from $10.5M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of OBCI and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, exiting entirely with an estimated $3.03M sold.
- 0 institutional investors held Ocean Bio-Chem Inc (OBCI) as of Q3 2022, down from 17 in Q2 2022.
- Funds reported $0 of Ocean Bio-Chem Inc stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new Ocean Bio-Chem Inc positions in Q3 2022 and 17 closed out, a net change of -17 holders.
- The largest Ocean Bio-Chem Inc seller in Q3 2022 was Renaissance Technologies, an estimated $3.03M sold.
Based on aggregated 13F filings for Q3 2022.